New CEO Michael Boyle Outlines ‘Cure, Care, Community’ Priorities for CFF
Jan 10, 2020 07:30 am | Larry Luxner
Michael Boyle, MD, has laid out a five-year strategic plan for the Cystic Fibrosis Foundation (CFF), following his Jan. 1 appointment as president and CEO of the Maryland-based charity. In a three-minute video message posted Jan. 9 to the CFF website, Boyle said the 2020-24 plan will focus on cure, care, and community. “After nearly […]
The post New CEO Michael Boyle Outlines ‘Cure, Care, Community’ Priorities for CFF appeared first on Cystic Fibrosis News Today. |
|
New CF Treatment Trikafta Now Available Through AllianceRx Walgreens Prime
Jan 09, 2020 07:00 am | Mary Chapman
Trikafta, a recently approved treatment for cystic fibrosis (CF), is now available through the U.S. home delivery and specialty pharmacy AllianceRx Walgreens Prime, as part of its limited distribution therapeutic offerings. Trikafta is a next-generation combination of three CF medications: elexacaftor, tezacaftor, and ivacaftor. Developed by Vertex Pharmaceuticals, the therapy was approved last October by […]
The post New CF Treatment Trikafta Now Available Through AllianceRx Walgreens Prime appeared first on Cystic Fibrosis News Today. |
|
|
No hay comentarios:
Publicar un comentario